PharmEasy IPO
IPO details from SEBI DRHP filings
Medium risk because:
- 1 material risk factors disclosed in DRHP
- mainboard IPO — compare pricing with sector peers
- issue at ₹ price band
IPOFins risk score from DRHP risk factors, subscription demand & issue structure
Subscription
—
About PharmEasy
PharmEasy is a consumer healthcare “super app” that provides consumers with on-demand, home delivered access to a wide range of prescription, OTC pharmaceuticals.
Company Details
Want to apply for this IPO?
Open a free Demat account and apply in minutes
FAQ
What is the price band of PharmEasy IPO?
The price band for PharmEasy IPO has not been announced yet. It is published in the RHP shortly before the issue opens.
What does PharmEasy do?
PharmEasy is a consumer healthcare “super app” that provides consumers with on-demand, home delivered access to a wide range of prescription, OTC pharmaceuticals.
Should I apply for PharmEasy IPO?
PharmEasy is a mainboard IPO with a ₹ price band ( issue) — subscription data is not live yet, so demand signals are unavailable. For a mainboard IPO at moderate risk (5/10), weigh DRHP financials and sector comps against the ₹ band before you apply.